Research Article
Novel Intravaginal Drug Delivery System Based on Molecularly PEGylated Lipid Matrices for Improved Antifungal Activity of Miconazole Nitrate
Table 1
Formulation composition of lipid matrices for SLMs preparation.
| ||||||||||||||||||||||||||||||||||||||||
Key: LM means lipid matrix prepared with super-refined sunseed oil and Softisan® 154; LM 1:1, LM 1:3, LM 1:6, and LM 1:9 are non-PEGylated lipid matrices containing increasing amounts of Softisan® 154; PEG-LM 1:1(1:9), PEG-LM 1:1(2:8), and PEG-LM 1:1(4:6) are PEGylated lipid matrices based on 1:1 ratio of sunseed oil and Softisan® 154 and containing increasing amounts of PEG 4000; PEG-LM 1:3(1:9), PEG-LM 1:3(2:8), and PEG-LM 1:3(4:6) are PEGylated lipid matrices based on 1:3 ratio of sunseed oil and Softisan® 154 and containing increasing amounts of PEG 4000; PEG-LM 1:6(1:9), PEG-LM 1:6(2:8), and PEG-LM 1:6(4:6) are PEGylated lipid matrices based on 1:6 ratio of sunseed oil and Softisan® 154 and containing increasing amounts of PEG 4000, while PEG-LM 1:9(1:9), PEG-LM 1:9(2:8), and PEG-LM 1:9(4:6) are PEGylated lipid matrices based on 1:9 ratio of sunseed oil and Softisan® 154 and containing increasing amounts of PEG 4000. |